Epigenetics in health and disease

L Zhang, Q Lu, C Chang - Epigenetics in allergy and autoimmunity, 2020 - Springer
Epigenetic mechanisms, which include DNA methylation, histone modification, and
microRNA (miRNA), can produce heritable phenotypic changes without a change in DNA …

DNA methylation profiles in cancer diagnosis and therapeutics

Y Pan, G Liu, F Zhou, B Su, Y Li - Clinical and experimental medicine, 2018 - Springer
Cancer initiation and proliferation is regulated by both epigenetic and genetic events with
epigenetic modifications being increasingly identified as important targets for cancer …

DNA methyltransferases: a novel target for prevention and therapy

D Subramaniam, R Thombre, A Dhar, S Anant - Frontiers in oncology, 2014 - frontiersin.org
Cancer is the second leading cause of death in US. Despite the emergence of new, targeted
agents, and the use of various therapeutic combinations, none of the available treatment …

[HTML][HTML] Common stemness regulators of embryonic and cancer stem cells

C Hadjimichael, K Chanoumidou… - World journal of stem …, 2015 - ncbi.nlm.nih.gov
Pluripotency of embryonic stem cells (ESCs) and induced pluripotent stem cells is regulated
by a well characterized gene transcription circuitry. The circuitry is assembled by ESC …

[PDF][PDF] MicroRNA‐dependent regulation of DNA methyltransferase‐1 and tumor suppressor gene expression by interleukin‐6 in human malignant cholangiocytes

C Braconi, N Huang, T Patel - Hepatology, 2010 - Wiley Online Library
Although the inflammation‐associated cytokine interleukin‐6 (IL‐6) has been implicated in
cholangiocarcinoma growth, the relationship between IL‐6 and oncogenic changes is …

DNMT3A in Leukemia

L Brunetti, MC Gundry… - Cold Spring …, 2017 - perspectivesinmedicine.cshlp.org
DNA methylation is an epigenetic process involved in development, aging, and cancer.
Although the advent of new molecular techniques has enhanced our knowledge of how …

[HTML][HTML] Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches

H Shabani, MH Karami, J Kolour, Z Sayyahi… - Biomedicine & …, 2023 - Elsevier
The rising incidence of breast cancer has been a significant source of concern in the
medical community. Regarding the adverse effects and consequences of current treatments …

DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation

SC Lai, YT Su, CC Chi, YC Kuo, KF Lee, YC Wu… - Journal of Experimental …, 2019 - Springer
Background The inflammatory cytokine interleukin-6 (IL-6) is critical for the expression of
octamer-binding transcription factor 4 (OCT4), which is highly associated with early tumor …

Molecular classification and novel targets in hepatocellular carcinoma: recent advancements

Y Hoshida, S Toffanin, A Lachenmayer… - Seminars in liver …, 2010 - thieme-connect.com
Hepatocellular carcinoma (HCC) is one of most lethal cancers worldwide. Strategic
decisions for the advancement of molecular therapies in this neoplasm require a clear …

[PDF][PDF] Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis

SLK Au, CCL Wong, JMF Lee, DNY Fan… - …, 2012 - Wiley Online Library
Epigenetic alterations and microRNA (miRNA) deregulation are common in hepatocellular
carcinoma (HCC). The histone H3 lysine 27 (H3K27) tri‐methylating enzyme, enhancer of …